Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck

Published:2009-04-21 Issue:1 Volume:65 Page:27-32
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Cho Byoung Chul,Keum Ki Chang,Shin Sang Joon,Choi Hye Jin,Lee Young Joo,Kim Se Hun,Choi Eun Chang,Kim Joo Hang

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-009-0999-4.pdf

Reference33 articles.

1. Stewart BW, Kleihues PE (2003) World cancer report. International Agency for Research on Cancer Press, Lyon, France

2. Kotwell C, Sako K, Zack MS, Rao U, Bakamjian V, Shedd DD (1987) Metastatic pattern in squamous cell cancer of the head and neck. Am J Surg 154:439–442

3. Zbaeren P, Lehmann W (1987) Frequency and sites of distant metastases in head and neck squamous cell carcinoma. Arch Otalaryngol Head Neck Surg 113:762–764

4. Seiwert TY, Cohen EE (2005) State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 92:1341–1348

5. Adelstein DJ, Li Y, Adams GL, Wagner H, Kish JA, Ensley JF et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92–98

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of cetuximab plus cisplatin alone and cetuximab plus cisplatin and paclitaxel regimen on humanistic outcome in head and neck cancer;Journal of the Egyptian National Cancer Institute;2023-01-19

2. Pharmacogenomic landscape of head and neck squamous cell carcinoma informs precision oncology therapy;Science Translational Medicine;2022-09-07

3. Real-world evidence with nivolumab in head-and-neck cancer: Access is key!;Cancer Research, Statistics, and Treatment;2022-07

4. Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health;The Oncologist;2021-07-27

5. Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan;Cancers;2021-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3